You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (30)

Journals (0)

1-10 of 30 results for ALK–TKI

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

Retricted access

Case report

First published 2024-12

Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs

Rita Leporati, Daniela Miliziano, Teresa Beninato [...]

Tumori Journal

Select article: Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Open access

Review article

First published 2018

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Tiziana Vavalà, Silvia Novello

Therapeutic Advances in Medical Oncology

Select article: Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Free access

Review article

First published 2016-5

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer

Ourania Romanidou, Lorenza Landi, Federico Cappuzzo [...]

Therapeutic Advances in Medical Oncology

Select article: Renal cyst formation complicating ALK inhibitors

Retricted access

Review article

First published 2023-6

Renal cyst formation complicating ALK inhibitors

Xiaomin Niu, Heather A Wakelee, Shuchi Anand

Journal of Onco-Nephrology

Select article: Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Open access

Research article

First published 2025-10

Hepatotoxicity of ALK/ROS1 tyrosine kinase inhibitors in non-small cell lung cancer patients: A pharmacovigilance study based on signal mining and analysis of the FDA adverse event reporting system database

Weixing Zhao, Xiaoni Jin, Yuan Li [...]

Science Progress

Select article: Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting

Open access

Review article

First published 2024-4

Alk-rearranged lung adenocarcinoma: From molecular genetics to therapeutic targeting

Ugo Testa, Germana Castelli, Elvira Pelosi

Tumori Journal

Select article: Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

Open access

Research article

First published 2024

Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase [...]

Therapeutic Advances in Medical Oncology

Select article: Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib

Retricted access

Case report

First published 2022-12

Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib

Mustafa Buyukkor, Fatih Tay, Ozturk Ates

Journal of Oncology Pharmacy Practice

Select article: Genotype-driven therapies for non-small cell lung cancer: focus on EGFR,KRAS and ALK gene abnormalities

Free access

Review article

First published 2011-5

Genotype-driven therapies for non-small cell lung cancer: focus on EGFR,KRAS and ALK gene abnormalities

Elizabeth M. Gaughan, Daniel B. Costa

Therapeutic Advances in Medical Oncology

Select article: Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Open access

Research article

First published 2024

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Rawan Dawoud, Harman Saman, Kakil Rasul [...]

Clinical Medicine Insights: Oncology

1
2
3
10 / page

Article type

Publication date

Subjects

Access